K. Sudo

发表

Enzymatic Hydrolysis of Woods - Part IX. Catalyzed Steam Explosion of Softwood

T. Fujii, T. Ishii, K. Sudo, 1986 .

Characterization of Steamed Wood Lignin from Beech Wood

K. Sudo, K. Shimizu, K. Sakurai, 1985 .

J. M. Pepper, K. Sudo, Donald J. Mullord, 1981 .

Structure elucidation of the antibiotic desertomycin through the use of new two-dimensional NMR techniques

A. Bax, A. Aszalos, Z. Dinya, 1987 .

Effect of ion suppression on judgment of enzyme inhibition and avoidance of error by utilizing a stable isotope-labeled probe substrate: example of CYP3A4 inhibition with [13C4,15N] labeled midazolam as a substrate.

N. Okudaira, K. Sudo, O. Okazaki, 2007, Drug metabolism and pharmacokinetics.

Structure Elucidation of the Antibiotic Desertomycin Through the Use of New Two-Dimensional NMR Techniques

Ad Bax, Adorjan Aszalos, A. Bax, 1987 .

Covalent Binding and Tissue Distribution/Retention Assessment of Drugs Associated with Idiosyncratic Drug Toxicity

H. Masumoto, Hideo Yukinaga, H. Takakusa, 2008, Drug Metabolism And Disposition.

A study of diseases caused by atypical mycobacteria in Japan.

K. Sudo, M. Yamamoto, M. Taga, 1967, The American review of respiratory disease.

Superiority of a new gradient system utilizing a critical threshold for the adsorption capacity of polypeptides to column packing when compared with a standard gradient system for the simultaneous and quantitative analysis of polypeptides.

H. Masumoto, K. Sudo, O. Okazaki, 2008, Biomedical chromatography : BMC.

Contribution of lysosomes to concentrative uptake of DX-9065a into rat liver.

K. Sudo, N. Murayama, M. Nakaoka, 2006, Journal of pharmaceutical sciences.

Metabolism-dependent hepatotoxicity of amodiaquine in glutathione-depleted mice

T. Izumi, Chiho Ono, R. Atsumi, 2009, Archives of Toxicology.

Markers of Electrophilic Stress Caused by Chemically Reactive Metabolites in Human Hepatocytes

H. Masumoto, H. Takakusa, K. Sudo, 2008, Drug Metabolism and Disposition.

Radioimmunoassay method for DX-9065a, an anticoagulant agent. Development, evaluation and application to human plasma.

K. Sudo, N. Murayama, T. Kikuchi, 1996, Journal of pharmaceutical and biomedical analysis.

Quantitative assessment of reactive metabolite formation using 35S-labeled glutathione.

H. Masumoto, H. Takakusa, K. Sudo, 2009, Drug metabolism and pharmacokinetics.

IN VITRO METABOLISM OF THE CALMODULIN ANTAGONIST DY-9760e (3-[2-[4-(3-CHLORO-2-METHYLPHENYL)-1-PIPERAZINYL]ETHYL]-5,6-DIMETHOXY-1-(4-IMIDAZOLYLMETHYL)-1H-INDAZOLE DIHYDROCHLORIDE 3.5 HYDRATE) BY HUMAN LIVER MICROSOMES: INVOLVEMENT OF CYTOCHROMES P450 IN ATYPICAL KINETICS AND POTENTIAL DRUG INTERACTI

H. Yokoyama, K. Sudo, O. Okazaki, 2005, Drug Metabolism and Disposition.

Ticlopidine-induced hepatotoxicity in a GSH-depleted rat model

H. Saji, T. Izumi, R. Atsumi, 2011, Archives of Toxicology.

Diagnostic criteria for disease caused by atypical mycobacteria.

K. Sudo, M. Yamamoto, S. Hibino, 1967, The American review of respiratory disease.

Elution mechanism of polypeptides in reversed-phase liquid chromatography based on the critical threshold of organic solvent to induce abrupt change in adsorption capacity to the column packing.

K. Sudo, R. Goda, 2008, Biomedical chromatography : BMC.

Disposition of timiperone, 4'-fluoro-4-[4-(2-thioxo-1-benzimidazolinyl)piperidino]butyrophenone, a neuroleptic, in the rat on repeated oral dosage.

K. Sudo, M. Sano, H. Tachizawa, 1981, Xenobiotica; the fate of foreign compounds in biological systems.

Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.

K. Sudo, M. Sano, H. Tachizawa, 1979, European journal of pharmacology.

Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.

Y. Sugiyama, X. Chu, Y. Kato, 1997, The Journal of pharmacology and experimental therapeutics.

Metabolism of the calmodulin antagonist DY-9760e in animals and humans

H. Iwata, M. Tanaka, K. Sudo, 2005, Xenobiotica; the fate of foreign compounds in biological systems.

Total utilisation of wood components by steam explosion pretreatment

T. Fujii, H. Ono, K. Sudo, 1994 .

Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys.

K. Sudo, O. Okazaki, M. Tsumura, 1986, Xenobiotica; the fate of foreign compounds in biological systems.

A new modification method of exploded lignin for the preparation of a carbon fiber precursor

A. Yokoyama, N. Nakashima, K. Sudo, 1993 .

A new carbon fiber from lignin

K. Sudo, K. Shimizu, 1992 .

Identification of cytochrome P450 3A4 modification site with reactive metabolite using linear ion trap-Fourier transform mass spectrometry.

H. Masumoto, Hideo Yukinaga, Z. Tozuka, 2007, Chemical research in toxicology.

Disposition and metabolism of timiperone in the rat, dog, and monkey.

H. Sasano, K. Sudo, M. Sano, 1981, Drug metabolism and disposition: the biological fate of chemicals.

Integrated process for total utilization of wood components by steam-explosion pretreatment

T. Fujii, H. Ono, K. Sudo, 1998 .

The Effects of Steamed Birch Feeding on the Feed Intake and Body Weight Gain of Holstein Steers

H. Kajikawa, F. Terada, T. Ishii, 1987 .

Metabolism of Ticlopidine in Rats: Identification of the Main Biliary Metabolite as a Glutathione Conjugate of Ticlopidine S-Oxide

R. Atsumi, K. Sudo, O. Okazaki, 2009, Drug Metabolism and Disposition.

Marked Strain Differences in the Pharmacokinetics of an α4β1 Integrin Antagonist, 4-[1-[3-Chloro-4-[N-(2-methylphenyl)-ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]-methoxybenzoic Acid (D01-4582), in Sprague-Dawley Rats Are Associated with Albumin Genetic Polymorphism

Y. Sugiyama, K. Sudo, Takashi Ito, 2007, Journal of Pharmacology and Experimental Therapeutics.

Development of a pretreatment method for amyloid beta-protein analysis based on the effect of acetic acid on the dissolution of plasma polypeptides.

H. Masumoto, K. Sudo, O. Okazaki, 2008, Biomedical chromatography : BMC.

Interindividual pharmacokinetics variability of the alpha(4)beta(1) integrin antagonist, 4-[1-[3-chloro-4-[N'-(2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]methoxybenzoic acid (D01-4582), in beagles is associated with albumin genetic polymorphisms.

Y. Sugiyama, K. Sudo, Takashi Ito, 2009, Journal of pharmaceutical sciences.

Risk Assessment for Drug-Drug Interaction Caused by Metabolism-Based Inhibition of CYP3A Using Automated in Vitro Assay Systems and Its Application in the Early Drug Discovery Process

N. Okudaira, K. Sudo, O. Okazaki, 2007, Drug Metabolism and Disposition.

The Thermal Degradation of Sugars. The Initial Products of Browning Reaction in Glucose Caramel

K. Sudo, H. Sugisawa, 1969 .

J. M. Pepper, K. Sudo, 1982 .

Steam-explosion treatment of two Malaysian hardwoods.

K. Sudo, M. Ishihara, Halimahton Mansor, 1990 .

Preliminary Studies on the Steam Explosion Pretreatment of the Oil Palm Stem

K. Sudo, M. Ishihara, Halimahton Mansor, 1990 .

Metabolism of ticlopidine in rats: Identification of the main biliary metabolite as a GSH conjugate of ticlopidine S-oxide

R. Atsumi, K. Sudo, O. Okazaki, 2009 .

Covalent Binding and Tissue Distribution/Retention Assessment of Drugs Associated with Idiosyncratic Drug Toxicity

H. Masumoto, Hideo Yukinaga, H. Takakusa, 2008, Drug Metabolism and Disposition.

Highly sensitive and quantitative analysis of polyeptides using a new gradient system based on an abrupt change in adsorption of polypeptide to the reversed-phase column packing.

K. Sudo, R. Goda, 2007, Biomedical chromatography : BMC.